Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Re: Comments on paper by Son et al.

Castegnaro M, Pfohl-Leszkowicz A, Bartsch H, Tillmann T, Mohr U.

Toxicol Lett. 2005 Apr 10;156(2):315; author reply 317. Epub 2005 Jan 18. No abstract available.

PMID:
15737494
[PubMed - indexed for MEDLINE]
2.
3.

Ochratoxin study.

Castegnaro M, Bartsch H, Tillmann T, Mohr U.

Int J Cancer. 2004 Dec 20;112(6):1083. No abstract available.

PMID:
15316941
[PubMed - indexed for MEDLINE]
4.

DNA ploidy distribution in renal tumours induced in male rats by dietary ochratoxin A.

Brown AL, Odell EW, Mantle PG.

Exp Toxicol Pathol. 2007 Oct;59(2):85-95. Epub 2007 Jul 16.

PMID:
17629687
[PubMed - indexed for MEDLINE]
5.

Ochratoxin A.

[No authors listed]

IARC Monogr Eval Carcinog Risk Chem Man. 1976;10:191-7. Review. No abstract available.

PMID:
791799
[PubMed - indexed for MEDLINE]
6.

Minimum tolerable exposure period and maximum threshold dietary intake of ochratoxin A for causing renal cancer in male Dark Agouti rats.

Mantle PG.

Food Chem Toxicol. 2009 Oct;47(10):2419-24. doi: 10.1016/j.fct.2009.05.043. Epub 2009 Jul 3.

PMID:
19577606
[PubMed - indexed for MEDLINE]
7.

Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin.

Kanisawa M, Suzuki S.

Gann. 1978 Aug;69(4):599-600. No abstract available.

PMID:
710809
[PubMed - indexed for MEDLINE]
8.

Two schedules of application for mesna and their influence on the thiol-metabolism.

Kempgens B, Kisro J, Gruber Y, Bahrs H, Wagner T.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):608-9. No abstract available.

PMID:
14692714
[PubMed - indexed for MEDLINE]
9.

MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma.

Marin-Kuan M, Nestler S, Verguet C, Bezençon C, Piguet D, Delatour T, Mantle P, Cavin C, Schilter B.

Toxicol Appl Pharmacol. 2007 Oct 15;224(2):174-81. Epub 2007 Jul 3.

PMID:
17651772
[PubMed - indexed for MEDLINE]
10.

Protective effect of MESNA (2-mercaptoethane sulfonate) against hepatic ischemia/reperfusion injury in rats.

Sener G, Sehirli O, Ercan F, Sirvanci S, Gedik N, Kacmaz A.

Surg Today. 2005;35(7):575-80.

PMID:
15976955
[PubMed - indexed for MEDLINE]
11.

[Anticarcinogenic effect of palustran on development of tumors induced by 3-(1-alpha-L-arabinopyranosyl)-1-methyl-1-nitrosourea (AMNU) in rats].

Sherenesheva NI, Fin'ko VE, Blanko FF, Alieva TA, Bedrina EN, Gogoleva IA, Klochkova TI.

Biull Eksp Biol Med. 1998 May;125(5):566-8. Russian. No abstract available.

PMID:
9644561
[PubMed - indexed for MEDLINE]
12.

Prophylaxis with mesna prevents oxidative stress induced by ischemia reperfusion in the intestine via inhibition of nuclear factor-kappaB activation.

Ypsilantis P, Tentes I, Lambropoulou M, Anagnostopoulos K, Papadopoulos N, Kortsaris A, Simopoulos C.

J Gastroenterol Hepatol. 2008 Feb;23(2):328-35. Epub 2007 Sep 12.

PMID:
17868332
[PubMed - indexed for MEDLINE]
13.

Inhibition of human sperm respiration by 4-hydroperoxycyclophosphamide and protection by mesna and WR-1065.

Badawy ZS, Souid AK.

Fertil Steril. 2009 Jan;91(1):173-8. doi: 10.1016/j.fertnstert.2007.11.008. Epub 2008 Jan 18.

PMID:
18206143
[PubMed - indexed for MEDLINE]
14.

Liver enzyme activities of rats exposed to ochratoxin A and T-2 toxin with antioxidants.

Atroshi F, Rizzo A, Sankari S, Biese I, Westermarck T, Veijalainen P.

Bull Environ Contam Toxicol. 2000 Apr;64(4):586-92. No abstract available.

PMID:
10754057
[PubMed - indexed for MEDLINE]
15.

Carcinogenicity and kinetic aspects of ochratoxin A.

Schlatter C, Studer-Rohr J, Rásonyi T.

Food Addit Contam. 1996;13 Suppl:43-4. Review. No abstract available.

PMID:
8972350
[PubMed - indexed for MEDLINE]
16.

Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms.

Marin-Kuan M, Cavin C, Delatour T, Schilter B.

Toxicon. 2008 Aug 1;52(2):195-202. doi: 10.1016/j.toxicon.2008.04.166. Epub 2008 May 29. Review.

PMID:
18649906
[PubMed - indexed for MEDLINE]
17.

[Current approaches to the study of carcinogenic safety, antineoplastic, anticarcinogenic and geroprotective effects of various pharmacologic preparations].

Anisimov VN, Zabezhinskiĭ MA, Popovich IG, Pliss GB, Bespalov VG, Aleksandrov VA, Stukov AN, Anikin IV, Alimova IN, Egormin PA, Panchenko AV, Piskunova TS, Semenchenko AV, Tyndyk ML, Iurova MN.

Vopr Onkol. 2012;58(1):7-18. Review. Russian. No abstract available.

PMID:
22629822
[PubMed - indexed for MEDLINE]
18.

Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.

Schwerdt G, Kirchhoff A, Freudinger R, Wollny B, Benesic A, Gekle M.

Pediatr Nephrol. 2007 Jun;22(6):798-803. Epub 2007 Feb 2.

PMID:
17273862
[PubMed - indexed for MEDLINE]
19.

Evidence of a new dechlorinated ochratoxin A derivative formed in opossum kidney cell cultures after pretreatment by modulators of glutathione pathways: correlation with DNA-adduct formation.

Faucet-Marquis V, Pont F, Størmer FC, Rizk T, Castegnaro M, Pfohl-Leszkowicz A.

Mol Nutr Food Res. 2006 May;50(6):530-42.

PMID:
16671059
[PubMed - indexed for MEDLINE]
20.

Abrogation of DEN/Fe-NTA induced carcinogenic response, oxidative damage and subsequent cell proliferation response by Terminalia chebula in kidney of Wistar rats.

Prasad L, Khan TH, Jahangir T, Sultana S.

Pharmazie. 2007 Oct;62(10):790-7.

PMID:
18236787
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk